AREV Life Sciences Global Corp. (AREVF)
OTCMKTS
· Delayed Price · Currency is USD
0.0100
0.00 (0.00%)
At close: Jan 27, 2025
AREV Life Sciences Global Cash Flow Statement
Financials in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | 2013 - 2017 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '23 Sep 30, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | 2013 - 2017 |
| Net Income | -0.24 | -1.44 | -0.99 | -1.05 | -3.19 | -8.27 | Upgrade
|
| Depreciation & Amortization | 0.07 | 0.13 | 0.15 | 0.15 | 0.07 | 0.05 | Upgrade
|
| Other Amortization | - | - | - | 0 | 0.03 | 0.02 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | - | - | 0.06 | - | - | Upgrade
|
| Asset Writedown & Restructuring Costs | - | - | - | 0.2 | 1.08 | 6.63 | Upgrade
|
| Loss (Gain) From Sale of Investments | - | - | - | 0.08 | - | - | Upgrade
|
| Stock-Based Compensation | -0.17 | 0.14 | 0.46 | 0.11 | 1.19 | 0.62 | Upgrade
|
| Provision & Write-off of Bad Debts | 0 | 0 | - | - | 0.04 | - | Upgrade
|
| Other Operating Activities | 0.01 | 0.04 | -0.71 | 0.01 | 0.05 | 0.04 | Upgrade
|
| Change in Accounts Receivable | -0.01 | 0.08 | -0 | -0 | -0.03 | 0.01 | Upgrade
|
| Change in Inventory | - | - | -0.02 | -0 | - | - | Upgrade
|
| Change in Accounts Payable | -0.11 | 0.56 | 0.15 | 0.18 | 0.36 | -0.22 | Upgrade
|
| Change in Other Net Operating Assets | 0.29 | 0.22 | -0.5 | 0.25 | 0.29 | 0 | Upgrade
|
| Operating Cash Flow | -0.15 | -0.28 | -1.47 | -0.02 | -0.11 | -1.1 | Upgrade
|
| Capital Expenditures | 0.01 | -0.03 | -0.01 | -0.31 | -0.22 | - | Upgrade
|
| Sale of Property, Plant & Equipment | - | - | 0.06 | - | - | - | Upgrade
|
| Sale (Purchase) of Intangibles | - | - | - | -0.1 | - | -0.05 | Upgrade
|
| Other Investing Activities | -0.05 | -0.05 | -0.05 | -0.03 | - | - | Upgrade
|
| Investing Cash Flow | -0.04 | -0.08 | -0.01 | -0.44 | -0.22 | -0.58 | Upgrade
|
| Short-Term Debt Issued | - | 0.01 | 0.31 | - | 0.1 | - | Upgrade
|
| Total Debt Issued | 0.11 | 0.01 | 0.31 | - | 0.1 | - | Upgrade
|
| Long-Term Debt Repaid | - | - | - | -0.05 | - | - | Upgrade
|
| Total Debt Repaid | 0.04 | - | - | -0.05 | - | - | Upgrade
|
| Net Debt Issued (Repaid) | 0.15 | 0.01 | 0.31 | -0.05 | 0.1 | - | Upgrade
|
| Issuance of Common Stock | 0.03 | 0.2 | 1.02 | 0.73 | 0.25 | 0.63 | Upgrade
|
| Other Financing Activities | - | - | - | 0.05 | - | - | Upgrade
|
| Financing Cash Flow | 0.18 | 0.21 | 1.34 | 0.73 | 0.35 | 0.63 | Upgrade
|
| Foreign Exchange Rate Adjustments | -0 | 0 | 0 | - | 0 | 0 | Upgrade
|
| Net Cash Flow | -0.01 | -0.16 | -0.14 | 0.27 | 0.02 | -1.05 | Upgrade
|
| Free Cash Flow | -0.14 | -0.31 | -1.48 | -0.33 | -0.33 | -1.1 | Upgrade
|
| Free Cash Flow Margin | -1931.00% | -633.36% | -581.17% | -174.04% | -168.90% | - | Upgrade
|
| Free Cash Flow Per Share | -0.00 | -0.01 | -0.08 | -0.02 | -0.04 | -0.17 | Upgrade
|
| Levered Free Cash Flow | -0.08 | 0.02 | -0.63 | -0.65 | 0.2 | -1.13 | Upgrade
|
| Unlevered Free Cash Flow | -0.08 | 0.02 | -0.6 | -0.62 | 0.22 | -1.13 | Upgrade
|
| Change in Net Working Capital | -0.13 | -0.65 | 0.16 | 0.09 | -1.07 | 0.64 | Upgrade
|
Updated Dec 8, 2023. Source: S&P Global Market Intelligence. Standard template. Financial Sources.